CA
NZ
UK
AU
IND
US
Gross profit rose 21% to USD 65.1 million. Operating expenses rose 20% to USD 92.5 million, with selling, general and administrative expense up USD 13.5 million to USD 72.5 million on sales andMarketingheadcount,Stock Compensationand consulting, andResearch and Developmentup 10% to USD 20.0 million. Loss …
Term Life adjusted operating revenues were roughly flat at USD 461.6 million, while its adjusted operating income before taxes fell 12% to USD 152.7 million from USD 172.7 million. Issued face amount declined 5% and policies issued fell 7% to 73,813. Recruits dropped 10% …
The company operates attractions and lodges in national parks and destinations in the United States, Canada, Iceland and Costa Rica. Same-store RevPAR rose 9.1% to USD 308.09, with occupancy at 92.3% and average daily rate up 6.5% to USD 333.79. Hospitality revenue grew 6.7% …
The filing explains the USD 0.35 decline in NAV per share through three channels. Net realized and unrealized losses cost USD 0.20 per weighted share, share issuance throughDividend reinvestmentand preferred conversions diluted NAV by USD 0.15, and distributions of USD 0.16 per weighted share …
Cost of revenue rose 51% to USD 19.0 million, mainly because the company sold clinical diagnostic tests ahead of Medicare reimbursement to gain market share, so payments were below testing costs. Diagnostic test costs added USD 3.5 million.Research and Developmentrose 32% to USD 16.1 …
Annual run rate, which the company says is not distorted by that timing, is the cleaner gauge. ARR excluding the divested Kepware and ThingWorx businesses was USD 2,508 million, up 8%, while the as-reported figure including prior-year divested ARR grew 1%. Full-year revenue was …
The chip segment, QCT, fell 3% to USD 37,208 million. Handsets dropped USD 3.7 billion to USD 24,072 million, while automotive rose 52% (calculated) to USD 6,004 million and IoT grew to USD 7,132 million from USD 6,617 million. QCT pretaxEarningswere USD 10,101 million, …
The second quarter outlook of USD 360 million to USD 380 million in revenue implies about 11% less than the first quarter at the midpoint (calculated), even though management frames it as 29% growth from a year earlier. Adjusted EBITDA guidance of USD 32 …
The cash build came from financing. A privatePlacementon May 28, 2026 sold 6,725,000 shares at USD 8.00 for net proceeds of USD 53.4 million. A public offering on July 16, 2026 sold 6,027,399 shares at USD 18.25 plus pre-funded warrants, for net proceeds of …
After quarter end, the company closed financings on October 30, 2026. These were 9,761,905 shares at USD 21.00 plus pre-funded warrants, USD 172.5 million of 2.25% convertible senior notes due 2032 and a concurrent privatePlacementof 1,428,571 shares. Net proceeds were approximately USD 215.7 million, …
Please wait processing your request...